Abstract
Contraceptive vaginal rings delivering various progestins alone or in combination with estrogen have been previously studied, showing adequate steroid vaginal absorption and acceptability by the users. Nestorone® progestin (NES) is a potent 19-nor-progesterone derivative, inactive by the oral route, but an excellent option for vaginal delivery. The purpose of this study was to evaluate ovarian function during 6 months of continuous use of progestin-only vaginal rings delivering 3 different doses of NES: 50, 75, and 100 μg per day. Blood samples were taken twice a week for 5 consecutive weeks during a control cycle and on months 1, 3 and 6 of use, for the measurement of estradiol (E2), progesterone (P), and NES. A total of 87 volunteers randomly received each of the 3 doses. After an initial peak, NES serum levels remained fairly constant throughout the duration of the study at about 125, 200 and 250 pmol/L, respectively, decreasing slightly with time. Luteal activity occurred very rarely (1.2–2.6% of sampling periods) with no apparent difference between doses. Low E2 levels (≤100 pmol/L) in all samples of a run were rare (5%) and only with the high dose ring (100 μg/day). E2 remained within normal levels (101–1500 pmol/L) in most of the segments studied. We conclude that the 50 and 75 μg/day NES rings provide adequate ovulation inhibition without hypoestrogenism, while the 100 μg/day ring may deliver an unnecessarily high dose.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call